Pharmacologic advances in the treatment and prevention of respiratory syncytial virus
LD Saravolatz, KM Empey… - Clinical Infectious …, 2010 - academic.oup.com
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
[PDF][PDF] Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
Clinical Infectious Diseases, 2010 - academia.edu
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus.
KM Empey, RS Peebles Jr… - Clinical Infectious …, 2010 - search.ebscohost.com
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
Pharmacologic advances in the treatment and prevention of respiratory syncytial virus
KM Empey, RS Peebles Jr… - … infectious diseases: an …, 2010 - pubmed.ncbi.nlm.nih.gov
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.
KM Empey, RSJ Peebles, JK Kolls - 2010 - cabidigitallibrary.org
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
[HTML][HTML] Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
KM Empey, RS Peebles Jr, JK Kolls - Clinical infectious diseases …, 2010 - ncbi.nlm.nih.gov
There are currently only two drugs approved for respiratory syncytial virus (RSV).
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …
Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.
KM Empey, RS Peebles Jr, JK Kolls - Clinical Infectious Diseases …, 2010 - europepmc.org
There are currently only two drugs approved for respiratory syncytial virus (RSV).
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …
Phannacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
KM Empey, RS Peebles Jr, JK Kolls - Clinical Infectious Diseases, 2010 - JSTOR
Currently, only 2 drugs have been approved for the treatment of respiratory syncytial virus
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
(RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children …
Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.
KM Empey, RS Peebles Jr, JK Kolls - Clinical Infectious Diseases …, 2010 - europepmc.org
There are currently only two drugs approved for respiratory syncytial virus (RSV).
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …
Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and …